Dudediligence.

Immunocore Holdings plc

IMCRNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$11.1M

8 notices · 326,332 sh

Oct 2025 to Oct 2026

Reported ·

$5,634,997

10 sales · 0 buys

Oct 2025 to Sep 2026

The two figures cover different periods.

6 of 10 reported sales carry the 10b5-1 box. Together they are 0.28% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Sep 2026N2025DJ2026FMAMJJASO2026-05-22: David Berman, Form 1442026-05-21: David Berman, Form 1442026-04-08: David Berman, Form 1442026-03-11: David Berman, Form 1442026-02-18: David Berman, Form 1442026-02-18: Tina St Leger, Form 1442026-02-18: Bahija Jallal, Form 1442025-11-24: David M. Berman, Form 1442025-11-24: Berman David M, sold2025-11-26: Berman David M, sold2025-12-04: Berman David M, sold2026-02-18: Jallal Bahija, sold2026-02-18: GOLL JOHN, sold2026-02-18: Berman David M, sold2026-02-18: St Leger Tina Amber, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-05-22David Berman, HEAD OF R&D$2,042,148
69,271 shno plan dateno Form 4 on file144 ↗
2026-05-21David Berman, HEAD OF R&D$1,894,638
65,000 shno plan dateno Form 4 on file144 ↗
2026-04-08David Berman, HEAD OF R&D$796,250
25,000 shno plan dateno Form 4 on file144 ↗
2026-03-11David Berman, HEAD OF R&D$385,330
11,832 shno plan dateno Form 4 on file144 ↗
2026-02-18David Berman, HEAD OF R&D$192,951
5,965 shno plan date144 ↗
Form 4, 2026-02-19: sold 5,965 at $32.35 Form 4 ↗
2026-02-18Tina St Leger, CHIEF HR OFFICER$32,347
1,000 shno plan date144 ↗
Form 4, 2026-02-19: sold 1,000 at $32.35 Form 4 ↗
2026-02-18Bahija Jallal, CHIEF EXECUTIVE OFFICER$371,152
11,474 shno plan date144 ↗
Form 4, 2026-02-19: sold 11,474 at $32.35 Form 4 ↗
2025-11-24David M. Berman, HEAD OF R&D$5,382,687
136,790 shplan 2025-05-09144 ↗
Form 4, 2025-11-26: sold 18,120 at $40.03 Form 4 ↗